Cardiomyocyte-derived GPX4 stabilizes BNIP3 to facilitate mitophagy and mitigate myocardial ischemia/reperfusion

Lingfeng Zhong1,2,3,4,5, Zhenfeng Cheng6, Yucong Zhang1,2

  • 1Department of Geriatric Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.

Nature Communications
|March 28, 2026
PubMed

Insights

Glutathione peroxidase 4 (GPX4) protects the heart during ischemia/reperfusion injury (MI/RI) by reducing mitochondrial damage. GPX4 stabilizes BNIP3, promoting mitophagy and preserving cardiac function.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Biochemistry

Background:

  • Myocardial ischemia/reperfusion injury (MI/RI) involves significant mitochondrial dysfunction.
  • The role of glutathione peroxidase 4 (GPX4) in MI/RI-induced mitochondrial damage is not fully understood.
  • GPX4 is a key regulator of ferroptosis, a cell death pathway linked to oxidative stress.

Purpose of the Study:

  • To investigate the effect and molecular mechanisms of GPX4 in myocardial ischemia/reperfusion injury (MI/RI).
  • To elucidate the role of GPX4 in regulating mitochondrial function and ferroptosis during MI/RI.

Main Methods:

  • Spatial transcriptomics, spatial proteomics, and single-cell sequencing were used to analyze GPX4 expression dynamics in MI/RI.
  • Experimental models were employed to assess the impact of cardiomyocyte-derived GPX4 on myocardial damage and mitochondrial function.
  • Molecular analyses were performed to identify the interaction partners and mechanisms involving GPX4.

Main Results:

  • GPX4 expression was significantly reduced in the ischemic region of the heart during MI/RI.
  • Cardiomyocyte-specific GPX4 overexpression mitigated myocardial damage, improved mitochondrial function, and reduced ventricular remodeling post-MI/RI.
  • GPX4 was found to enhance the interaction between BNIP3 and USP20, reducing BNIP3 ubiquitination, stabilizing BNIP3, and promoting mitophagy.

Conclusions:

  • GPX4 plays a protective role in MI/RI by preserving mitochondrial function and reducing ferroptosis-related damage.
  • The GPX4/BNIP3/USP20 complex is a critical mediator of cardioprotection during MI/RI.
  • Targeting the GPX4 pathway offers a potential therapeutic strategy for managing MI/RI and related cardiac conditions.

Related Concept Videos